Growth Stocks To Follow Now - November 19th

Prologis logo with Real Estate background
Image from MarketBeat Media, LLC.

Prologis, Ascendis Pharma A/S, and Pershing Square are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies that investors expect to increase their revenue or earnings faster than the market average. These companies often reinvest profits to expand, and their stock prices may be more volatile because they can depend heavily on expectations of future growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Shares of Prologis stock traded down $2.08 on Thursday, hitting $123.14. 1,045,135 shares of the company were exchanged, compared to its average volume of 3,772,792. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.61. Prologis has a 1-year low of $122.61 and a 1-year high of $153.35. The company has a 50-day moving average price of $129.99 and a 200 day moving average price of $137.70. The stock has a market capitalization of $117.04 billion, a price-to-earnings ratio of 27.24, a price-to-earnings-growth ratio of 1.43 and a beta of 1.27.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Shares of Ascendis Pharma A/S stock traded down $9.16 on Thursday, reaching $261.17. 388,996 shares of the company were exchanged, compared to its average volume of 701,674. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.89 and a quick ratio of 2.29. Ascendis Pharma A/S has a 1-year low of $188.08 and a 1-year high of $282.15. The company has a market cap of $16.29 billion, a P/E ratio of 17.05 and a beta of 0.40. The stock's 50 day moving average price is $242.90 and its 200-day moving average price is $240.53.

Read Our Latest Research Report on ASND

Pershing Square (PS)

We are an alternative asset management company that manages pools of permanent capital invested in long-term, high-return investment strategies. Our growth is principally driven by the long-term compounding of our assets under management and the opportunistic launch of new permanent capital vehicles that enable us to pursue new investment verticals or to pursue our core investment strategies in new jurisdictions.

Shares of NYSE:PS traded down $3.31 on Thursday, reaching $37.29. The company's stock had a trading volume of 1,381,019 shares, compared to its average volume of 425,381. The stock's 50-day moving average is $48.12 and its two-hundred day moving average is $40.73. The stock has a market capitalization of $14.92 billion and a P/E ratio of 143.42. Pershing Square has a 52-week low of $22.01 and a 52-week high of $60.40.

Read Our Latest Research Report on PS

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Prologis Right Now?

Before you consider Prologis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.

While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines